Evaluation of strategies to modify Anti-SARS-CoV-2 monoclonal antibodies for optimal functionality as therapeutics
Author(s) -
Robert V. House,
Thomas Broge,
Todd J. Suscovich,
Doris M. Snow,
Milan T. Tomic,
Genevieve H. t,
Kamaljit Bajwa,
Guangyu Zhu,
Zachary Martinez,
Kyal Hackett,
Christopher G. Earnhart,
Nicole M. Dorsey,
Svetlana A. Hopkins,
Dalia S. Natour,
Heather D. Davis,
Michael S. Anderson,
Melicia R. Gainey,
Ronald R. Cobb
Publication year - 2022
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0267796
Subject(s) - monoclonal antibody , epitope , antibody , virology , immunology , virus , population , immune system , pandemic , biology , disease , medicine , covid-19 , infectious disease (medical specialty) , environmental health
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom